These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31081042)

  • 1. Transaminitis and neutropenia are rare in patients on methotrexate: evidence from a large cohort of inflammatory arthritis patients.
    Malley T; Corfield G; Fung P; Heneghan D; Kitchen J
    Rheumatology (Oxford); 2019 Nov; 58(11):2061-2062. PubMed ID: 31081042
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantifying the hepatotoxic risk of alcohol consumption in patients with rheumatoid arthritis taking methotrexate.
    Humphreys JH; Warner A; Costello R; Lunt M; Verstappen SMM; Dixon WG
    Ann Rheum Dis; 2017 Sep; 76(9):1509-1514. PubMed ID: 28341765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Not yet time to change the guidelines for monitoring methotrexate liver toxicity: they have served us well.
    Kremer JM
    J Rheumatol; 2002 Aug; 29(8):1590-2. PubMed ID: 12180714
    [No Abstract]   [Full Text] [Related]  

  • 4. Non-alcoholic steatohepatitis-like pattern in liver biopsy of rheumatoid arthritis patients with persistent transaminitis during low-dose methotrexate treatment.
    Mori S; Arima N; Ito M; Fujiyama S; Kamo Y; Ueki Y
    PLoS One; 2018; 13(8):e0203084. PubMed ID: 30142184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient increase of aminotransferases in RA patients treated with methotrexate.
    Lacki JK; Samborski W; Machiewicz SH
    Z Rheumatol; 1993; 52(4):232-5. PubMed ID: 8212923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transaminase Levels and Hepatic Events During Tocilizumab Treatment: Pooled Analysis of Long-Term Clinical Trial Safety Data in Rheumatoid Arthritis.
    Genovese MC; Kremer JM; van Vollenhoven RF; Alten R; Scali JJ; Kelman A; Dimonaco S; Brockwell L
    Arthritis Rheumatol; 2017 Sep; 69(9):1751-1761. PubMed ID: 28597609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comment on: Hepatotoxicity rates do not differ in patients with rheumatoid arthritis and psoriasis treated with methotrexate.
    Lynch M; Kirby B
    Rheumatology (Oxford); 2010 Jan; 49(1):196-7; author reply 197-8. PubMed ID: 19858119
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk of elevated liver enzymes associated with TNF inhibitor utilisation in patients with rheumatoid arthritis.
    Sokolove J; Strand V; Greenberg JD; Curtis JR; Kavanaugh A; Kremer JM; Anofrei A; Reed G; Calabrese L; Hooper M; Baumgartner S; Furst DE;
    Ann Rheum Dis; 2010 Sep; 69(9):1612-7. PubMed ID: 20448284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of etanercept and methotrexate in patients with rheumatoid arthritis and hepatitis C virus infection: a multicenter randomized clinical trial.
    Iannone F; La Montagna G; Bagnato G; Gremese E; Giardina A; Lapadula G
    J Rheumatol; 2014 Feb; 41(2):286-92. PubMed ID: 24429167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of less frequent monitoring of liver transaminases levels in rheumatic patients treated with low-dose methotrexate.
    Khabbazi A; Kolahi S; Dastgiri S; Hajialiloo M; Nazeri M; Nazeri L; Sheikholeslami Salmasi A; Gader S; Bak Mohammad Zadeh S; Ghasemi A; Poormohammad A
    Int J Rheum Dis; 2014 Jul; 17(6):646-52. PubMed ID: 24965662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune hepatitis as an adverse effect of long-term methotrexate therapy.
    Ksouda K; Affes H; Atheymen R; Ezzeddine M; Zeghal K; Hammami S
    Indian J Pharmacol; 2014; 46(6):649-50. PubMed ID: 25538339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring for methotrexate hepatotoxicity in patients with rheumatoid arthritis: another hepatologist's perspective.
    Lewis JH
    J Rheumatol; 1997 Aug; 24(8):1459-60. PubMed ID: 9263133
    [No Abstract]   [Full Text] [Related]  

  • 13. Association between cumulative methotrexate dose, non-invasive scoring system and hepatic fibrosis detected by Fibroscan in rheumatoid arthritis patients receiving methotrexate.
    Lertnawapan R; Chonprasertsuk S; Siramolpiwat S
    Int J Rheum Dis; 2019 Feb; 22(2):214-221. PubMed ID: 30565876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Methotrexate, liver and rheumatoid arthritis in tropical areas].
    Diouf ML; Diallo S; Mbengue M; Moreira-Diop T
    Sante; 2001; 11(3):195-200. PubMed ID: 11641084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injectable gold-induced hepatitis and neutropenia in rheumatoid arthritis.
    Uhm WS; Yoo DH; Lee JH; Kim TH; Jun JB; Lee IH; Bae SC; Kim SY
    Korean J Intern Med; 2000 Jul; 15(2):156-9. PubMed ID: 10992732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe hepatotoxicity in a rheumatoid arthritis patient switched from leflunomide to methotrexate.
    Gupta R; Gupta SK
    MedGenMed; 2005 Sep; 7(3):9. PubMed ID: 16369235
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk of hepatotoxicity with add-on leflunomide in rheumatoid arthritis patients.
    Gupta R; Bhatia J; Gupta SK
    Arzneimittelforschung; 2011; 61(5):312-6. PubMed ID: 21755815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate therapy, rheumatoid arthritis, and life-threatening liver complications: should we be monitoring more closely?
    Tugnet N; Cooper SC; Douglas KM
    Scand J Rheumatol; 2012 Mar; 41(2):163-4. PubMed ID: 22420415
    [No Abstract]   [Full Text] [Related]  

  • 19. Methotrexate Hepatotoxicity in Rheumatoid Arthritis: An Analysis of the Physicians' Policy.
    Anvari B
    Curr Rheumatol Rev; 2020; 16(1):67-73. PubMed ID: 31244428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring methotrexate hepatic toxicity in rheumatoid arthritis: is it time to update the guidelines?
    Yazici Y; Erkan D; Paget SA
    J Rheumatol; 2002 Aug; 29(8):1586-9. PubMed ID: 12180713
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.